Desuzumab for knee osteoarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests a new medicine called Desuzumab for knee osteoarthritis. It looks at whether the medicine can help reduce pain and improve joint function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old
- You have been diagnosed with knee osteoarthritis by a doctor
- You have not taken any medication that could affect the study results recently
- You do not have any serious health conditions like diabetes, thyroid problems, bone disease, or cancer
- You are willing to follow the study rules and come to all visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well different pain medicines work for knee osteoarthritis and looks at brain patterns to understand why some people get more relief. It may help you find a treatment that works best for you.
This study tests whether a painless microneedle patch containing the drug denosumab is safe to use on the skin. It is for healthy adults or people with osteoarthritis and osteoporosis who have no skin issues or certain medication use.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.